lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR

• Published in: Molecular therapy Vol. 28; no. 1; pp. 9 - 18
• Main Authors: Wan-Xin, Peng, Koirala, Pratirodh, Zhang, Wei, Ni, Chao, Wang, Zheng, Liu, Yang, Yin-Yuan, Mo
• Format: Journal Article
• Language: English
• Published: Milwaukee Elsevier Limited 08.01.2020; American Society of Gene & Cell Therapy
• Subjects: Cancer; CRISPR; Deoxyribonucleic acid; DNA; DNA methylation; DNA methyltransferase; Ectopic expression; Gene expression; HuR protein; Original; Proteins; Rhabdomyosarcoma; Ribonucleic acid; RNA; RNA-binding protein; Transcription
• ISSN: 1525-0016; 1525-0024
• DOI: 10.1016/j.ymthe.2019.09.024

Large bodies of studies have shown that the CRISPR/Cas9-based library screening is a very powerful tool for the identification of gene functions. However, most of these studies have focused on protein-coding genes, and, furthermore, very few studies have used gene reporters for screening. In the present study, we generated DNA methyltransferase 3B (DNMT3B) reporter and screened a CRISPR/Cas9 synergistic activation mediator (SAM) library against a focused group of lncRNAs. With this screening approach, we identified Rhabdomyosarcoma 2-Associated Transcript (RMST) as a positive regulator for DNMT3B. This was confirmed by activation of the endogenous RMST by SAM or ectopic expression of RMST. Moreover, RMST knockout (KO) suppresses DNMT3, while rescue with RMST in the KO cells restores the DNMT3 level. Finally, RMST KO suppresses global DNA methylation, leading to the upregulation of methylation-regulated genes. Mechanistically, RMST promotes the interaction between the RNA-binding protein HuR and DNMT3B 3′ UTR, increasing the DNMT3B stability. Together, these results not only provide the feasibility of a reporter system for CRISPR library screening but also demonstrate the previously uncharacterized factor RMST as an important player in the modulation of DNA methylation.